1.
Dear Editor,
We read with interest the trial by Kaila et al. comparing digital music intervention (DMI), conventional music therapy (CMT), and standard care across the dementia care continuum. 1 We appreciate the candid reporting of null primary cognitive outcomes. Building on the authors’ own observations, we offer some thoughts on how intervention components, therapeutic context, and outcome selection may together shape such results.
We first note a measurement issue. Kaila et al. averaged self‐ and proxy‐rated scores when both were available. 1 In dementia, self‐ and proxy ratings often diverge, especially as severity and anosognosia increase. 2 Internal states like anxiety and mood are particularly vulnerable, since informants must infer them from behavior. Notably, the trial's clearest emotional signal, reduced anxiety after CMT, came from a purely self‐rated instrument (PROMIS Anxiety), while several other emotional outcomes used averaged or proxy ratings. 1 This does not explain every null result. Still, averaging may dilute effects visible through one channel only. Future trials should prespecify rater‐specific analyses. Self‐proxy discordance may itself be informative about mechanism, not just noise.
A related issue concerns endpoints. The authors acknowledge that global measures like Montreal Cognitive Assessment may be insensitive to short‐term change; outcome selection should follow the presumed mechanism of action. 3 Two domains seem better matched to music's active ingredients. First, anxiety. CMT's anxiety reduction in community‐dwelling participants was confined to sensitivity analyses. 1 Yet it aligns with controlled evidence that receptive music reduces anxiety in Alzheimer's disease 4 and with Cochrane support for emotional and behavioral benefits. 5 For trials enriching samples for baseline symptoms, anxiety may be a credible primary endpoint. Second, autobiographical memory (AM). Maintenance of prompted AM under both formats fits the rationale that musical memory draws on preserved neural structures. 1 However, elevating AM to a primary endpoint may require better instruments. The trial used partly custom measures, 1 and tools like the Brief Autobiographical Recollection Test were designed for individual differences, not longitudinal change. 6 Nor did the DMI effect survive sensitivity analysis in the care home sample. 1 Replication and validation should come first.
The authors reasonably attribute CMT's broader benefits to therapeutic relationship, session flexibility, and social interaction. They also note that the DMI arm was not uniform: Care home participants attended in person, while community‐dwelling participants joined online. 1 These explanations could be made testable. Therapeutic alliance could be prespecified as a mediator, measured with tools adapted for cognitive impairment, at least in milder subsamples; alliance is widely seen as a core process in music therapy. Delivery mode and facilitator type could also be crossed factorially (digital vs live, therapist vs trained facilitator), consistent with complex‐intervention guidance on components and context. 7 This would keep “digital” from being treated as one category. That matters here: the trial's qualitative feedback about technical problems and weaker online connection came mostly from community‐dwelling participants. 1
The selective CMT benefits are unlikely to be explained solely by active ingredients missing from DMI. Both arms contained receptive and expressive components in similar proportions, and the exploratory direct comparison found no significant differences. 1 As an underpowered analysis of selected outcomes, however, it cannot establish equivalence. 1 The improvement in the standard care group, which the authors attribute to general supportive aspects of participation, 1 is a recognized phenomenon in dementia trials. 8 This suggests that structurally matched attention controls are needed to separate music‐specific effects from the social engagement that group interventions provide.
Finally, the dyad remains underexplored. Caregiver outcomes did not show significant intervention effects in the main analyses. 1 Home‐based music programs increasingly treat music as a shared resource within patient‐caregiver dyads. 9 As home and digital formats expand, the dyad rather than the individual patient may be the more informative unit of intervention and analysis.
The trial helps clarify the boundaries of current designs. Future studies should select endpoints that match the intervention's mechanism, enrich samples for targeted symptoms, prespecify rater‐specific and mediator analyses, and compare components and contexts rather than delivery channels alone. We thank the authors for advancing this evidence base.
CONFLICT OF INTEREST STATEMENT
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Author disclosures are available in the Supporting Information.
GENERATIVE AI STATEMENT
The authors used DeepSeek‐V4.1‐Flash solely for language polishing. The authors reviewed and edited the content and take full responsibility for the final version.
Supporting information
Supporting Information: trc270341‐sup‐0001‐SuppMat.docx
ICMJE Disclosure Form
ACKNOWLEDGMENT
The authors thank Kaila and colleagues for their careful and transparent reporting of the trial, which prompted this correspondence. No other assistance or contributions requiring acknowledgment were received for this work.
REFERENCES
- 1. Kaila LM, Salakka I, Pitkäniemi A, et al. Digital music intervention and music therapy across the dementia care continuum: Randomized controlled trial. Alzheimers Dement 2026;12:e70317. doi: 10.1002/trc2.70317 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Conde‐Sala JL, Reñé‐Ramírez R, Turró‐Garriga O, et al. Severity of dementia, anosognosia, and depression in relation to the quality of life of patients with Alzheimer disease: Discrepancies between patients and caregivers. Am J Geriatr Psychiatry 2014;22:138‐147. doi: 10.1016/j.jagp.2012.07.001 [DOI] [PubMed] [Google Scholar]
- 3. Jutten RJ, Papp KV, Hendrix S, et al. Why a clinical trial is as good as its outcome measure: a framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease. Alzheimers Dement 2023;19:708‐720. doi: 10.1002/alz.12773 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Guétin S, Portet F, Picot MC, et al. Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: randomised, controlled study. Dement Geriatr Cogn Disord 2009;28:36‐46. doi: 10.1159/000229024 [DOI] [PubMed] [Google Scholar]
- 5. van der Steen JT, van der Wouden JC, Methley AM, Smaling HJA, Vink AC, Bruinsma MS. Music‐based therapeutic interventions for people with dementia. Cochrane Database Syst Rev 2025;3:CD003477. doi: 10.1002/14651858.CD003477.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Berntsen D, Hoyle RH, Rubin DC. The autobiographical recollection test (ART): a measure of individual differences in autobiographical memory. J Appl Res Mem Cogn 2019;8:305‐318. doi: 10.1016/j.jarmac.2019.06.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. BMJ 2021;374:n2061. doi: 10.1136/bmj.n2061 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Nichols LO, Martindale‐Adams JL, Burns R, Graney MJ, Zuber JK, Kennedy SE. Potential explanations for control group benefit. Clin Trials 2012;9:588‐595. doi: 10.1177/1740774512455876 [DOI] [PubMed] [Google Scholar]
- 9. McMahon K, McFerran K, Clark IN, et al. Learning to use music as a resource: The experiences of people with dementia and their family care partners participating in a home‐based skill‐sharing music intervention: A HOMESIDE sub‐study. Front Med 2023;10:1205784. doi: 10.3389/fmed.2023.1205784 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information: trc270341‐sup‐0001‐SuppMat.docx
ICMJE Disclosure Form
